United States Meningococcal Vaccines Market Report 2016

December 2016 | 100 pages | ID: U6F72B793F7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Meningococcal Vaccines

Revenue, means the sales value of Meningococcal Vaccines

This report studies sales (consumption) of Meningococcal Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• Sanofi Pasteur
• Merck
• Decartis
• Pfizer
• bioCSL (Seqirus)
• Protein Sciences

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Meningococcal Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Meningococcal Vaccines Market Report 2016

1 MENINGOCOCCAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Meningococcal Vaccines
1.2 Classification of Meningococcal Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Meningococcal Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Meningococcal Vaccines (2011-2021)
  1.4.1 United States Meningococcal Vaccines Sales and Growth Rate (2011-2021)
  1.4.2 United States Meningococcal Vaccines Revenue and Growth Rate (2011-2021)

2 UNITED STATES MENINGOCOCCAL VACCINES COMPETITION BY MANUFACTURERS

2.1 United States Meningococcal Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Meningococcal Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Meningococcal Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Meningococcal Vaccines Market Competitive Situation and Trends
  2.4.1 Meningococcal Vaccines Market Concentration Rate
  2.4.2 Meningococcal Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MENINGOCOCCAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Meningococcal Vaccines Sales and Market Share by Type (2011-2016)
3.2 United States Meningococcal Vaccines Revenue and Market Share by Type (2011-2016)
3.3 United States Meningococcal Vaccines Price by Type (2011-2016)
3.4 United States Meningococcal Vaccines Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MENINGOCOCCAL VACCINES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Meningococcal Vaccines Sales and Market Share by Application (2011-2016)
4.2 United States Meningococcal Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MENINGOCOCCAL VACCINES MANUFACTURERS PROFILES/ANALYSIS

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Meningococcal Vaccines Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sanofi Pasteur
  5.2.2 Meningococcal Vaccines Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sanofi Pasteur Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck
  5.3.2 Meningococcal Vaccines Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Decartis
  5.4.2 Meningococcal Vaccines Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Decartis Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Meningococcal Vaccines Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 bioCSL (Seqirus)
  5.6.2 Meningococcal Vaccines Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 bioCSL (Seqirus) Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Protein Sciences
  5.7.2 Meningococcal Vaccines Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Protein Sciences Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 MENINGOCOCCAL VACCINES MANUFACTURING COST ANALYSIS

6.1 Meningococcal Vaccines Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Meningococcal Vaccines

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Meningococcal Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MENINGOCOCCAL VACCINES MARKET FORECAST (2016-2021)

10.1 United States Meningococcal Vaccines Sales, Revenue Forecast (2016-2021)
10.2 United States Meningococcal Vaccines Sales Forecast by Type (2016-2021)
10.3 United States Meningococcal Vaccines Sales Forecast by Application (2016-2021)
10.4 Meningococcal Vaccines Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Meningococcal Vaccines
Table Classification of Meningococcal Vaccines
Figure United States Sales Market Share of Meningococcal Vaccines by Type in 2015
Table Application of Meningococcal Vaccines
Figure United States Sales Market Share of Meningococcal Vaccines by Application in 2015
Figure United States Meningococcal Vaccines Sales and Growth Rate (2011-2021)
Figure United States Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Table United States Meningococcal Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Meningococcal Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meningococcal Vaccines Sales Share by Manufacturers
Figure 2016 Meningococcal Vaccines Sales Share by Manufacturers
Table United States Meningococcal Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Meningococcal Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Meningococcal Vaccines Revenue Share by Manufacturers
Table 2016 United States Meningococcal Vaccines Revenue Share by Manufacturers
Table United States Market Meningococcal Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Meningococcal Vaccines Average Price of Key Manufacturers in 2015
Figure Meningococcal Vaccines Market Share of Top 3 Manufacturers
Figure Meningococcal Vaccines Market Share of Top 5 Manufacturers
Table United States Meningococcal Vaccines Sales by Type (2011-2016)
Table United States Meningococcal Vaccines Sales Share by Type (2011-2016)
Figure United States Meningococcal Vaccines Sales Market Share by Type in 2015
Table United States Meningococcal Vaccines Revenue and Market Share by Type (2011-2016)
Table United States Meningococcal Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meningococcal Vaccines by Type (2011-2016)
Table United States Meningococcal Vaccines Price by Type (2011-2016)
Figure United States Meningococcal Vaccines Sales Growth Rate by Type (2011-2016)
Table United States Meningococcal Vaccines Sales by Application (2011-2016)
Table United States Meningococcal Vaccines Sales Market Share by Application (2011-2016)
Figure United States Meningococcal Vaccines Sales Market Share by Application in 2015
Table United States Meningococcal Vaccines Sales Growth Rate by Application (2011-2016)
Figure United States Meningococcal Vaccines Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Meningococcal Vaccines Sales Market Share (2011-2016)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Pasteur Meningococcal Vaccines Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Meningococcal Vaccines Sales Market Share (2011-2016)
Table Decartis Basic Information List
Table Decartis Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Decartis Meningococcal Vaccines Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Meningococcal Vaccines Sales Market Share (2011-2016)
Table bioCSL (Seqirus) Basic Information List
Table bioCSL (Seqirus) Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table bioCSL (Seqirus) Meningococcal Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Basic Information List
Table Protein Sciences Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Meningococcal Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningococcal Vaccines
Figure Manufacturing Process Analysis of Meningococcal Vaccines
Figure Meningococcal Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2015
Table Major Buyers of Meningococcal Vaccines
Table Distributors/Traders List
Figure United States Meningococcal Vaccines Production and Growth Rate Forecast (2016-2021)
Figure United States Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table United States Meningococcal Vaccines Production Forecast by Type (2016-2021)
Table United States Meningococcal Vaccines Consumption Forecast by Application (2016-2021)